• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bactericidal activity of ofloxacin versus roxithromycin in the treatment of Streptococcus pneumoniae.

作者信息

Shah P M, Schäfer V, Hubener T, Metz C, Stille W

机构信息

Klinikum der J.W. Goethe-Universität, Zentrum der Inneren Medizin, Infektiologie, Frankfurt am Main.

出版信息

Drugs. 1987;34 Suppl 1:9-13. doi: 10.2165/00003495-198700341-00003.

DOI:10.2165/00003495-198700341-00003
PMID:3481332
Abstract

Ofloxacin is highly active against Gram-negative aerobic bacilli, but moderately active against Gram-positive cocci. The minimal inhibitory concentrations (MICs) against Streptococcus pneumoniae range between 1 and 2 mg/L. MICs of roxithromycin (RU 28965) against S. pneumoniae range between 0.004 and 0.03 mg/L, but Gram-negative bacilli are resistant. The bactericidal activities of ofloxacin and roxithromycin were evaluated against 15 strains of S. pneumoniae, which were isolated recently from clinical specimens. Killing activity was evaluated under conditions simulating serum pharmacokinetic parameters. Initial concentrations were 10 mg/L for roxithromycin and 2 mg/L for ofloxacin, and the half-life was 6 hours for both compounds. Under these conditions, roxithromycin was rapidly bactericidal. The speed at which pneumococci were killed was faster with roxithromycin than with ofloxacin. No regrowth was seen with roxithromycin, but regrowth occurred in 8 of 15 strains with ofloxacin.

摘要

相似文献

1
Bactericidal activity of ofloxacin versus roxithromycin in the treatment of Streptococcus pneumoniae.
Drugs. 1987;34 Suppl 1:9-13. doi: 10.2165/00003495-198700341-00003.
2
Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.U-70138F(帕地霉素)、罗红霉素(RU 965)和氧氟沙星(ORF 18489)在细胞培养中对沙眼衣原体的抗菌活性。
Antimicrob Agents Chemother. 1986 Nov;30(5):806-7. doi: 10.1128/AAC.30.5.806.
3
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].氧氟沙星对流感嗜血杆菌、肺炎链球菌和脑膜炎奈瑟菌的作用。与同类分子的比较
Pathol Biol (Paris). 1985 May;33(5):385-8.
4
Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.阿奇霉素对大环内酯类敏感和耐药肺炎链球菌的药效学活性,模拟临床可达到的游离血清、上皮衬液和中耳液浓度。
J Antimicrob Chemother. 2003 Jul;52(1):83-8. doi: 10.1093/jac/dkg278. Epub 2003 May 29.
5
[Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].5种大环内酯类药物:罗红霉素、红霉素、竹桃霉素、交沙霉素和螺旋霉素对284株医院分离菌株的体外抑菌和杀菌效果比较
Pathol Biol (Paris). 1989 Jun;37(5 Pt 2):553-9.
6
Susceptibility in vitro of gram-positive aerobe and anaerobe bacteria to ofloxacin.革兰氏阳性需氧菌和厌氧菌对氧氟沙星的体外敏感性
Drugs Exp Clin Res. 1987;13(4):213-7.
7
[Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].RP 59,500(奎奴普丁-达福普汀),首个半合成注射用链阳菌素,对革兰氏阳性球菌及其他近期临床病原体的抗菌活性比较
Jpn J Antibiot. 1997 Oct;50(10):844-53.
8
[In vitro activity of roxithromycin against hospital bacteria and the concordance curve].[罗红霉素对医院细菌的体外活性及协同曲线]
Pathol Biol (Paris). 1988 May;36(5):420-4.
9
The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.革兰氏阴性菌和革兰氏阳性菌对氧氟沙星的敏感性。
Drugs Exp Clin Res. 1987;13(9):555-61.
10
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.交沙霉素对需氧革兰氏阳性球菌和厌氧菌的体外活性。
Antimicrob Agents Chemother. 1976 Jun;9(6):988-93. doi: 10.1128/AAC.9.6.988.

引用本文的文献

1
Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.罗红霉素:抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1989 Jan;37(1):8-41. doi: 10.2165/00003495-198937010-00002.

本文引用的文献

1
An improved method to study antibacterial activity of antibiotics in an in vitro model simulating serum levels.一种在模拟血清水平的体外模型中研究抗生素抗菌活性的改进方法。
Methods Find Exp Clin Pharmacol. 1980 Aug;2(4):171-6.
2
In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugs.三种新型大环内酯类抗菌剂RU28965、RU29065和RU29702的体外评价及与其他口服药物的比较。
Antimicrob Agents Chemother. 1983 Aug;24(2):209-15. doi: 10.1128/AAC.24.2.209.
3
An experimental model for the study of the antibacterial activity of the sulfonamides.
Chemotherapia (Basel). 1968;13(1):54-60. doi: 10.1159/000220530.
4
[Respiratory tract infections--clinical results with ofloxacin].[呼吸道感染——氧氟沙星的临床疗效]
Infection. 1986;14 Suppl 1:S79-81. doi: 10.1007/BF01645206.